Brazil's Anvisa seizes counterfeit NAC, suspends Fauldleuco batch over particulates

Brazil's health regulator Anvisa seized a falsified batch of NAC supplement and suspended a batch of Fauldleuco injectable drug due to suspected particulate matter. The actions indicate quality-control failures in the pharmaceutical supply chain, potentially affecting patient safety and triggering recalls. The extent of distribution and health impact remains unclear.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works